-
KLDO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Kaleido Biosciences (KLDO)
Company Profile
Quarter (USD) | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.64 mm | 40.64 mm | 40.64 mm | 40.64 mm | 40.64 mm | 40.64 mm |
Cash burn (monthly) | 5.73 mm | 645.67 k | 6.57 mm | 7.31 mm | 5.72 mm | 6.42 mm |
Cash used (since last report) | 204.97 mm | 23.11 mm | 234.98 mm | 261.44 mm | 204.70 mm | 229.91 mm |
Cash remaining | -164.33 mm | 17.53 mm | -194.35 mm | -220.80 mm | -164.06 mm | -189.27 mm |
Runway (months of cash) | -28.7 | 27.1 | -29.6 | -30.2 | -28.7 | -29.5 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 0 |
Closed positions | 60 |
Increased positions | 0 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 128.37 mm |
Total shares | 12.09 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Flagship Ventures Fund V | 9.76 mm | $111.65 mm |
HarbourVest Partners | 1.83 mm | $16.69 mm |
Artal | 500.50 k | $31.00 k |
Captrust Financial Advisors | 129.00 | $0.00 |
Close Asset Management | 100.00 | $0.00 |